A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs

Inclusion Criteria: * Participants must have a first or confirmed diagnosis of Spondyloarthritis (SpA) according to Assessment of Spondyloarthritis classification (ASAS) criteria * Participants must be naïve to conventional, targeted and biological Disease modifying anti-rheumatic drugs (DMARDs) treatment * Participants must understand the purpose of the study * Participants must sign a participation agreement/ Informed Consent Form (ICF) allowing data collection and source data verification in accordance with local requirements Exclusion Criteria: * Participants who already started conventional, targeted and biological DMARDs treatment for SpA * Participants who participate to an investigational study in the last 30 days * Participants unwilling or unable to participate in long-term, 24 months, data collection * Participants unwilling or unable to fill in the Participant-reported outcome (PRO) foreseen by the protocol * Participants unwilling or unable to sign the informed consent to the study